The src‐family kinase inhibitor PP2 suppresses the <i>in vitro</i> invasive phenotype of bladder carcinoma cells via modulation of Akt

Abstract

These results show that PP2 inhibits bladder carcinoma cell growth and can modulate plakoglobin expression in a subset of cell lines. In addition, PP2 can suppress the in vitro invasive capacity of bladder carcinoma cells by modulating the activation status of Akt.